Monopar Therapeutics Inc's total assets for Q4 2025 were $140.72B, an increase of 97487.13% from the previous quarter. MNPR total liabilities were $2.89B for the fiscal quarter, a 109375.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.